Advice on anabolic steroid estra-4,9-diene-3,17-dione

Document type
Guidance note
Publisher
Advisory Council on the Misuse of Drugs
Date of publication
14 January 2016
Subject(s)
Substance Misuse
Collection
Social welfare
Material type
Reports

Download (41KB )

This guidance from the Advisory Council on the Misuse of Drugs (ACMD) recommends the control of this substance due its potential physical and social harms.  The anabolic steroid estra-4,9-diene-3,17-dione is also known by the following chemical names: dienedione , 19-norandrosta-4,9(10)-diene-3,17-dione and 19-nor-4,9(10)-androstadienedione.  It is prohibited by the World Anti-Doping Agency and UK Anti-Doping requested ACMD consider it for control under the Misuse of Drugs Act.  This substance was identified in four products sold in fitness shops in the UK. Anabolic steroids are synthetic substances which are related to the male sex hormones, particularly testosterone. These substances have a number of physiological effects.  The recommendations for classification of anabolic steroids potentially associated with sport, body building and image enhancement are based on demand reduction, harm minimisation and reduction of supply.

Related to Substance Misuse

Drug misuse and dependence: UK guidelines on clinical management

Downloadable guidelines on treating people with drug misuse and drug dependence problems

Family drug and alcohol court national unit: independent evaluation: research report

The family drug and alcohol court (FDAC) offers an alternative form of care proceedings for children put at risk of significant…

Fourth addendum to ACMD’s report on synthetic cannabinoids

This addendum recommends revisions to the regulations regarding the scheduling of synthetic cannabinoids. Specifically, they…

More items related to this subject